2019 - Fellow of the Indian National Academy of Engineering (INAE)
Jonathan Himmelfarb spends much of his time researching Internal medicine, Kidney disease, Hemodialysis, Dialysis and Surgery. Jonathan Himmelfarb combines subjects such as Gastroenterology and Endocrinology with his study of Internal medicine. He has researched Kidney disease in several fields, including Nephrology, Renal function, Diabetes mellitus, Intensive care medicine and Disease.
Jonathan Himmelfarb interconnects Heart disease and Risk factor in the investigation of issues within Hemodialysis. His Dialysis research is multidisciplinary, relying on both Fistula, Randomized controlled trial, Intensive care, Arteriovenous fistula and Severity of illness. His studies in Surgery integrate themes in fields like Platelet aggregation inhibitor, ABO blood group system, Confidence interval and Cardiology.
Jonathan Himmelfarb focuses on Internal medicine, Kidney disease, Hemodialysis, Dialysis and Intensive care medicine. The concepts of his Internal medicine study are interwoven with issues in Diabetes mellitus and Endocrinology. His research on Kidney disease also deals with topics like
His biological study spans a wide range of topics, including Gastroenterology, Arteriovenous fistula and Cardiology. Jonathan Himmelfarb has included themes like Urea, Urology, Mortality rate, Randomized controlled trial and Severity of illness in his Dialysis study. The various areas that he examines in his Intensive care medicine study include Clinical trial, Disease and Sepsis.
His scientific interests lie mostly in Kidney disease, Internal medicine, Kidney, Acute kidney injury and Dialysis. The study incorporates disciplines such as Precision medicine, End stage renal disease, Confidence interval, Prospective cohort study and In vivo in addition to Kidney disease. His study in Internal medicine is interdisciplinary in nature, drawing from both Diabetes mellitus and Oncology.
His Kidney research is multidisciplinary, incorporating elements of Pharmacokinetics and Cell biology. His work deals with themes such as Laser capture microdissection, Vasopressin, Endothelial dysfunction and Hazard ratio, which intersect with Acute kidney injury. His Dialysis study integrates concerns from other disciplines, such as Nausea, Anesthesia, Quality of life, Placebo and Hemodialysis.
His main research concerns Kidney disease, Internal medicine, Dialysis, Acute kidney injury and Renal function. Jonathan Himmelfarb undertakes multidisciplinary studies into Kidney disease and Imaging data in his work. His Internal medicine study frequently links to other fields, such as Diabetes mellitus.
His research integrates issues of Wearable computer, Artificial kidney, Intensive care medicine, Treatment options and Hemodialysis in his study of Dialysis. The Acute kidney injury study combines topics in areas such as Vasopressin, Pharmacologic intervention, Bioinformatics and Endothelial dysfunction. His research in Renal function intersects with topics in Nephrology, Interquartile range and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
Jonathan Himmelfarb;Jonathan Himmelfarb;Peter Stenvinkel;Peter Stenvinkel;T. Alp Ikizler;T. Alp Ikizler;Raymond M. Hakim;Raymond M. Hakim.
Kidney International (2002)
Acute Kidney Injury Increases Risk of ESRD among Elderly
Areef Ishani;Jay L. Xue;Jonathan Himmelfarb;Paul W. Eggers.
Journal of The American Society of Nephrology (2009)
Spectrum of acute renal failure in the intensive care unit: The PICARD experience
Ravindra L. Mehta;Maria T. Pascual;Sharon Soroko;Brandon R. Savage.
Kidney International (2004)
Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury
Josée Bouchard;Sharon B. Soroko;Glenn M. Chertow;Jonathan Himmelfarb.
Kidney International (2009)
Incidence and Mortality of Acute Renal Failure in Medicare Beneficiaries, 1992 to 2001
Jay L. Xue;Frank Daniels;Robert A. Star;Paul L. Kimmel.
Journal of The American Society of Nephrology (2006)
Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.
B Payson Oberg;Elizabeth McMenamin;Elizabeth McMenamin;F Lee Lucas;F Lee Lucas;Ellen McMonagle;Ellen McMonagle.
Kidney International (2004)
Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States
Ian H. de Boer;Tessa C. Rue;Yoshio N. Hall;Patrick J. Heagerty.
Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for Hemodialysis: A Randomized Controlled Trial
Laura M. Dember;Gerald J. Beck;Michael Allon;James A. Delmez.
Kidney Disease and Increased Mortality Risk in Type 2 Diabetes
Maryam Afkarian;Michael C. Sachs;Bryan Kestenbaum;Irl B. Hirsch.
Journal of The American Society of Nephrology (2013)
Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism
T. Alp Ikizler;Noel J. Cano;Harold Franch;Denis Fouque.
Kidney International (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: